Results of NRG-RTOG 0436 highlight need for biomarkers in treatment of esophageal cancer
NRG-RTOG 0436 has determined that adding an epidermal growth factor receptor (EGFR) inhibitor to a chemo-radiation regimen does not improve overall survival for patients with locally advanced esophageal cancer treated in ...
Jul 25, 2017
0
0